Vanguard Group
DRTX

Vanguard Group’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Vanguard Group’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-375,304
Closed -$4.76M – 4073
2014
Q3 		$4.76M Buy
375,304
+54,437
+17% +$813K ﹤0.01% 2856
2014
Q2 		$5.46M Buy
320,867
+21,480
+7% +$320K ﹤0.01% 2792
2014
Q1 		$4.03M Buy
299,387
+41,116
+16% +$539K ﹤0.01% 2935
2013
Q4 		$3.3M Buy
258,271
+2,575
+1% +$27K ﹤0.01% 2989
2013
Q3 		$2.31M Buy
255,696
+577
+0.2% +$4.79K ﹤0.01% 3082
2013
Q2 		$1.84M Buy
+255,119
New +$1.87M ﹤0.01% 3093

Vanguard Group's DRTX Position: Q4 2014 in Review

Vanguard Group sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 375,304 shares — an estimated $4.76M sold.

Vanguard Group first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $5.46M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Vanguard Group reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Vanguard Group sold 375,304 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $4.76M.
  • Vanguard Group first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Vanguard Group's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $5.46M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Vanguard Group's 13F filing for Q4 2014, filed 12 Feb 2015.